Publication
International arbitration report
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Canada | Update | March 17, 2020 4 PM ET
Immigration, Refugees and Citizenship Canada (IRCC) published an updated set of special measures to help temporary and permanent residents conserve and/or obtain their rights to remain or work in Canada during the outbreak. These measures include:
• Temporary residence applicants from outside Canada
• Permanent residence applicants
• Citizenship applicants
As expected, we have noted an increase in processing times in applications being processed in China, Iran and South Korea.
A dedicated channel has also been created by IRCC for applicants in China, Iran and South Korea needing a visitor visa, study permit or work permit urgently to travel to Canada.
Beyond these measures, IRCC’s position is that of business as usual. This means that foreign nationals remain responsible for ensuring they have the correct legal authorizations to remain and work in Canada even if they are obliged to stay in Canada longer than expected due to the outbreak.
Notably, IRCC has also indicated that the physical presence requirement will not be lessened for permanent residents. This is important for permanent residents who might not be able to travel back to Canada for an extended period.
Employers should remember:
Publication
In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023